dermaGPT
ResourcesContact Us
Book a Demo

Give us the product.
Get MoCRA covered.

Compliance, AI computed.

MoCRA requires the responsible person named on the label to register the facility, list the product with the FDA, hold adequate substantiation of safety and report serious adverse events within 15 business days. dermaGPT keeps the records, builds the substantiation from the same product record as your EU file, and tells you when a listing goes stale.

Book a dermaGPT demo

MoCRA requires outcomes rather than a defined dossier: adequate substantiation on record, accurate listings, a working adverse-event process. The evidence overlaps with the EU file; the filings do not.

What MoCRA requires

The Modernization of Cosmetics Regulation Act of 2022 gave the FDA its first real inventory of the cosmetics market.

01Who is accountable

The responsible person on the label

The manufacturer, packer or distributor named on the label carries most of the duties, whoever operates the plant. Foreign brands marketing in the US are covered.

02Facilities and products

Registration and listing

Manufacturing facilities register with the FDA and every product is listed, with its ingredients, on separate renewal cycles. A reformulation, a new shade or a new product updates the listing.

03Safety

Adequate substantiation on record

Records that actually support the safety of the product, which the FDA may require access to. A well-built CPSR carries most of this weight; the reverse does not hold.

04Adverse events

A 15-business-day clock

Serious adverse events are reported to the FDA within 15 business days, which needs a defined intake, triage and reporting process, not a mailbox.

Give us the product record, get the MoCRA file

The same product record that builds your EU file supplies the US substantiation; the filings and the labelling rules are handled separately.

What you give us

  1. 01Formula with the concentration of every ingredient
  2. 02Supplier specifications, CoA and SDS
  3. 03Label artwork with the responsible person and the ingredient declaration
  4. 04Facility details and the products made there

What you get

  1. 01Ingredient check against US restrictions and the FDA's current guidance at your use level
  2. 02Safety substantiation records built from the product's toxicological and exposure data
  3. 03Facility registration and product listing data, kept in step with the formula and the shade list
  4. 04An adverse-event record with the 15-business-day reporting clock built in
  5. 05Alerts when FDA guidance or a listed ingredient's status changes

How the MoCRA file is built

Four steps from product record to a listed, substantiated product.

01

Check every ingredient

Each substance is screened against the US restrictions and the FDA's current position, at your concentration and product type.

02

Build the substantiation

The toxicological profiles, exposure and safety reasoning are assembled into records the FDA can be shown on request.

03

Register and list

Facility registration and the product listing are compiled from the same record, so the ingredients on file match the ones in the product.

04

Watch and report

Listings are updated when the product changes, and serious adverse events run through a defined 15-business-day process.

Where MoCRA files go wrong

The findings that come up most often, and what the record has to show instead.

Common findings

Assuming the manufacturer dealt with it
The responsible person on the label carries the duties, whoever operates the plant.
Facility registered, product not listed
Two separate obligations on separate renewal cycles.
Substantiation as a filing exercise
The records must support the safety of the product; the FDA may require access to them.
No adverse-event procedure
A 15-business-day clock cannot be met without intake, triage and reporting steps.
Stale listings
A reformulation, a new shade or a new product requires the listing to be updated.
Assuming the EU file transfers unchanged
The evidence largely does; the filings, the labelling and the reporting mechanics do not.

Our strengths

Beyond compliance documentation.

Verify the data behind every compliance decision.

Not just generating compliance documents: verifying the data and the evidence behind every compliance judgement.

Three reasons to choose dermaGPT

  • 01

    Regulatory Intelligence

    Complex regulations compiled into executable check logic.

  • 02

    Data Verification

    Recalculate and cross-check to surface inconsistencies and latent problems.

  • 03

    Evidence Traceability

    Every finding traces back to the source document, page and revision.

dermaGPT in numbers

Documents processed
1,000,000+
13,000× faster time-to-market
10 min
Botanical studies analyzed
20,000+
Trusted by 500+ businesses

Manual report preparation

2 months per product

With dermaGPT

As fast as 10 minutes

Evidence collection and the assessor's review are separate steps; the file itself is generated in minutes.

Read more

  • What is MoCRA?
  • PIF vs CPSR
  • What is a cosmetic safety assessment?

Every ingredient, every market

  • Every ingredient cleared for every market.

  • Signed by qualified assessors.

  • Rule changes, mapped to your products.

  • Inspection-ready at any moment.

  • One record, every market.

See dermaGPT on your own products.

A short walkthrough with our team, built around your formulas and the markets you sell in.

Book a Demo

Unlock growth with dermaGPT

Learn how systematic AI can optimize formula performance and elevate product portfolio outcomes.

dermaGPT

End-to-end AI solutions for R&D efficacy prediction, production compliance, and smart recommendations.

Product

  • Home
  • Markets
  • Resources
  • FAQ

Solutions

  • EU PIF / CPSR
  • US MoCRA
  • ASEAN PIF
  • PPWR Technical Documentation
  • Label Compliance Report
  • Claims & Advertising Compliance Report
  • REACH / CLP Compliance Report

About

  • Privacy Policies
  • Cookies Policy

Headquarters

VesCir Ltd.

10F.-1, No. 155, Sec. 3, Xinyi Rd., Da'an Dist., Taipei City 106, Taiwan

+886 2 2507 6729

service@vescir.com

Netherlands Branch

VesCir Holland BV

WTC The Hague, Prinses Margrietplantsoen 33, 2595 AM Den Haag, The Netherlands

service@vescir.com

©2026 dermaGPT|All rights reserved